Eli Lilly and Company
6-Fluoro-2-Methylbenzo[d]thiazol-5-yl Compounds
Last updated:
Abstract:
The present invention provides a compound of Formula I: ##STR00001## wherein R is hydrogen or methyl; and Z is: ##STR00002## or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating neurodegenerative diseases, such as Alzheimer's disease.
Status:
Application
Type:
Utility
Filling date:
28 Jul 2020
Issue date:
12 Nov 2020